​

Syndax Pharmaceuticals (SNDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Syndax Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$23.68M

Latest Revenue (Q)

$12.50M

Main Segment (Y)

Milestone Revenue

Syndax Pharmaceuticals Revenue by Period

Syndax Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$23.68M100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$139.71M9109.56%
2020-12-31$1.52M-
2019-12-31$1.52M-
2018-12-31$1.52M-28.04%
2017-12-31$2.11M72.79%
2016-12-31$1.22M94.58%
2015-12-31$627.00K100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Syndax Pharmaceuticals generated $23.68M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 1560.98% compared to the same period a year ago.

Syndax Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$12.50M257.14%
2024-06-30$3.50M100.00%
2024-03-31--100.00%
2023-12-31$536.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$126.58M922.84%
2021-09-30$12.38M3165.17%
2021-06-30$379.00K-
2021-03-31$379.00K-0.26%
2020-12-31$380.00K0.26%
2020-09-30$379.00K-
2020-06-30$379.00K-
2020-03-31$379.00K-0.26%
2019-12-31$380.00K0.26%
2019-09-30$379.00K-
2019-06-30$379.00K-
2019-03-31$379.00K-0.26%
2018-12-31$380.00K0.26%
2018-09-30$379.00K-
2018-06-30$379.00K-
2018-03-31$379.00K-68.23%
2017-12-31$1.19M291.15%
2017-09-30$305.00K-
2017-06-30$305.00K-
2017-03-31$305.00K-
2016-12-31$305.00K-
2016-09-30$305.00K-
2016-06-30$305.00K-
2016-03-31$305.00K-
2015-12-31$305.00K-
2015-09-30$305.00K1694.12%
2015-06-30$17.00K100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Syndax Pharmaceuticals generated $12.50M in revenue during Q3 2024, up 257.14% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Syndax Pharmaceuticals Revenue Breakdown

Syndax Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Milestone Revenue$16.00M
Net Product Revenues$7.68M

Syndax Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Milestone Revenue (67.57%), and Net Product Revenues (32.43%).

Syndax Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
STROSutro Biopharma$62.04M$25.71M
MRSNMersana Therapeutics$40.50M$12.60M
MRUSMerus$36.13M$11.77M
SNDXSyndax Pharmaceuticals$23.68M$12.50M
CYTKCytokinetics$18.47M$463.00K
KROSKeros Therapeutics$3.55M$37.00K
CGEMCullinan Oncology--
PCVXVaxcyte--
COGTCogent Biosciences--
KALVKalVista Pharmaceuticals--
VRDNViridian Therapeutics-$86.00K
RVMDRevolution Medicines--
EWTXEdgewise Therapeutics--
REPLReplimune Group--
AVTEAerovate Therapeutics--
INZYInozyme Pharma--
DYNDyne Therapeutics--
MLYSMineralys Therapeutics--
PLRXPliant Therapeutics--
LRMRLarimar Therapeutics--

SNDX Revenue FAQ

What is Syndax Pharmaceuticals’s yearly revenue?

Syndax Pharmaceuticals's yearly revenue for 2024 was $23.68M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. SNDX's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is Syndax Pharmaceuticals’s quarterly revenue?

Syndax Pharmaceuticals's quarterly revenue for Q3 2024 was $12.5M, a 257.14% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $3.5M, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). SNDX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Syndax Pharmaceuticals’s revenue growth rate?

Syndax Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 1460.98%.

What are Syndax Pharmaceuticals’s revenue streams?

Syndax Pharmaceuticals's revenue streams in c 24 are Milestone Revenue, and Net Product Revenues. Milestone Revenue generated $16M in revenue, accounting 67.57% of the company's total revenue Net Product Revenues generated $7.68M in revenue, accounting 32.43% of the company's total revenue

What is Syndax Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Syndax Pharmaceuticals was Milestone Revenue. This segment made a revenue of $16M, representing 67.57% of the company's total revenue.